These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12120626)

  • 41. Effect of sibutramine and of cognitive-behavioural weight loss therapy in obesity and subclinical binge eating disorder.
    Bauer C; Fischer A; Keller U
    Diabetes Obes Metab; 2006 May; 8(3):289-95. PubMed ID: 16634988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The anti-obesity drug sibutramine for overweight diabetic patients. "Blood pressure is not elevated")].
    Matiba B
    MMW Fortschr Med; 2002 Jul; 144(27-28):16; author reply 17. PubMed ID: 12198873
    [No Abstract]   [Full Text] [Related]  

  • 43. Great expectations: "I'm losing 25% of my weight no matter what you say".
    Wadden TA; Womble LG; Sarwer DB; Berkowitz RI; Clark VL; Foster GD
    J Consult Clin Psychol; 2003 Dec; 71(6):1084-9. PubMed ID: 14622084
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K; Finer N; Rössner S
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of sibutramine intake on resting and exercise physiological responses.
    Rotstein A; Inbar O; Vaisman N
    Ann Nutr Metab; 2008; 52(1):17-23. PubMed ID: 18230966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy of obesity].
    Hunecke I
    Z Arztl Fortbild (Jena); 1980 Jul; 74(13-14):609-13. PubMed ID: 7434796
    [No Abstract]   [Full Text] [Related]  

  • 47. Effects of acute and chronic protein intake on metabolism, appetite, and ghrelin during weight loss.
    Leidy HJ; Mattes RD; Campbell WW
    Obesity (Silver Spring); 2007 May; 15(5):1215-25. PubMed ID: 17495198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pharmacotherapy for weight loss in patients with type 2 diabetes].
    Toubro S
    Ugeskr Laeger; 2007 Aug; 169(33):2619-22. PubMed ID: 17725907
    [No Abstract]   [Full Text] [Related]  

  • 49. Does genetic testing for obesity influence confidence in the ability to lose weight? A pilot investigation.
    Harvey-Berino J; Gold EC; West DS; Shuldiner AR; Walston J; Starling RD; Nolan A; Silver K; Poehlman ET
    J Am Diet Assoc; 2001 Nov; 101(11):1351-3. PubMed ID: 11716317
    [No Abstract]   [Full Text] [Related]  

  • 50. The effect of a medium-term activity- and diet-induced energy deficit on subjective appetite sensations in obese children.
    King NA; Hester J; Gately PJ
    Int J Obes (Lond); 2007 Feb; 31(2):334-9. PubMed ID: 16718282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
    Tallett AJ; Blundell JE; Rodgers RJ
    Behav Brain Res; 2009 Mar; 198(2):359-65. PubMed ID: 19061919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Will a pill take your pounds off?
    Consum Rep; 1996 Aug; 61(8):15-7. PubMed ID: 10182466
    [No Abstract]   [Full Text] [Related]  

  • 53. Combined dietary and pharmacological weight management in obese hypopituitary patients.
    Mersebach H; Klose M; Svendsen OL; Astrup A; Feldt-Rasmussen U
    Obes Res; 2004 Nov; 12(11):1835-43. PubMed ID: 15601980
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of various methods of treatment of obesity on the hypothalamo-hypophyseal system and thyroid function].
    Marova EI; Piskunova GG; Korotkova VD; Mokina MV
    Sov Med; 1981; (8):13-8. PubMed ID: 7292140
    [No Abstract]   [Full Text] [Related]  

  • 55. Multivitamin and dietary supplements, body weight and appetite: results from a cross-sectional and a randomised double-blind placebo-controlled study.
    Major GC; Doucet E; Jacqmain M; St-Onge M; Bouchard C; Tremblay A
    Br J Nutr; 2008 May; 99(5):1157-67. PubMed ID: 17977472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does prior authorization of sibutramine improve medication compliance or weight loss?
    Risser JA; Vash PD; Nieto L
    Obes Res; 2005 Jan; 13(1):86-92. PubMed ID: 15761166
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation and treatment of obesity.
    Azar ST; Zantout MS
    J Med Liban; 2000; 48(5):310-4. PubMed ID: 12489585
    [No Abstract]   [Full Text] [Related]  

  • 58. [Sibutramin in obesity treatment (multicenter, open, prospective 12-month-long study)].
    Payer J; Hainer V; Ondrejka P; Kajtor Z
    Vnitr Lek; 2004 Nov; 50(11):825-9. PubMed ID: 15648961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Principles of the treatment of obesity].
    Hochrein M; Schleicher I
    Med Monatsschr; 1966 Sep; 20(9):395-402. PubMed ID: 5975336
    [No Abstract]   [Full Text] [Related]  

  • 60. A clinical view of the obesity problem.
    Pi-Sunyer X
    Science; 2003 Feb; 299(5608):859-60. PubMed ID: 12574620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.